Previous studies by our laboratory and others have suggested that Sema4A could be a significant and direct contributor to oligodendrocyte cell loss and subsequent demyelination or white matter damage in diseases such as MS [6, 10, 21], HIV infection [5], neuroinflammation [28], and even cerebral malaria [29]. This evidence concerns the gene SEMA4A and myeloid sarcoma.